Showing results (81-90 of 94) with videos related to
Sort By:
Pageof 10
BMC Surgery|May 27, 2026
Cervical esophagogastric anastomosis using a retrosternal gastric conduit in an adult patient with congenial type A long-gap esophageal atresia after 18 years of gastrostomy: a case reportMasahiro Kohmoto, Takeshi Yamashita, Satoru Goto, et al.Journal of Surgical Case Reports|August 31, 2017
A long-term survival case after surgical resection of skeletal muscle metastasis following esophagectomy for squamous cell carcinoma of the esophagusAkira Saito, Masahiko Murakami, Koji Otsuka, et al.Case Reports in Gastroenterology|July 13, 2016
Intrathoracic Hernia after Total GastrectomyYoshihiko Tashiro, Masahiko Murakami, Koji Otsuka, et al.Langenbeck'S Archives of Surgery|March 12, 2016
Routes for virtually guided endoscopic liver resection of subdiaphragmatic liver tumorsTakeshi Aoki, Masahiko Murakami, Akira Fujimori, et al.Bioorganic & Medicinal Chemistry|August 6, 2008
TX-2152: a conformationally rigid and electron-rich diyne analogue of FTY720 with in vivo antiangiogenic activityShinichi Nakayama, Yoshihiro Uto, Kanako Tanimoto, et al.The American Surgeon|November 3, 2021
Clinical Treatment of Perioperative Disseminated Intravascular Coagulation in Patients Who Underwent Gastrointestinal and Hepato-Biliary-Pancreatic SurgeryKodai Tomioka, Takeshi Aoki, Kazuhiro Matsuda, et al.Anticancer Research|April 28, 2025
Efficacy of Esophagectomy Following Neoadjuvant Chemotherapy for Esophageal Neuroendocrine CarcinomaTakeshi Yamashita, Koichiro Fujimasa, Koji Otsuka, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 31, 2018
[Present and Future of Navigation Surgery in Hepatobiliary and Pancreatic Surgery]Takeshi Aoki, Yoshihiko Tashiro, Tomotake Koizumi, et al.Anticancer Research|July 20, 2021
Indocyanine Green Fluorescence Image-guided Laparoscopic Hepatectomy Enabled Resection of a Tumor Invisible With UltrasonographyKeisuke Oura, Takeshi Aoki, Yoshihiko Tashiro, et al.Frontiers in Oncology|October 28, 2024
Chemotherapy combined with immune checkpoint inhibitors may overcome the detrimental effect of high neutrophil-to-lymphocyte ratio prior to treatment in esophageal cancer patientsYuya Hirasawa, Yutaro Kubota, Emiko Mura, et al.Pageof 10